trending Market Intelligence /marketintelligence/en/news-insights/trending/S8YdNjm-vJF3GgSwy7hokg2 content esgSubNav
In This List

Swedish biopharma Hansa Medical to change name

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Swedish biopharma Hansa Medical to change name

Hansa Medical AB (publ) will change its name to Hansa Biopharma AB.

Bolagsverket, also known as the Swedish Companies Registration Office, approved the name change.

The name change was approved by shareholders during the biopharmaceutical company's Dec. 4 extraordinary general meeting.

Lund, Sweden-based Hansa, which focuses on treatment and prevention of rare and severe autoimmune conditions and transplant rejection, said the name change will be implemented in the next days and weeks, and the company's ticker has changed to HNSA from HMED.